Stay updated on Phase 2 DaxibotulinumtoxinA Clinical Trial
Sign up to get notified when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.

Latest updates to the Phase 2 DaxibotulinumtoxinA Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check11 days agoChange DetectedThe clinical trial record for a Phase 2 study of daxibotulinumtoxinA for plantar fasciitis is displayed, including its study plan, participant criteria, locations, and outcome measures.SummaryDifference48%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check32 days agoChange DetectedA general NIH announcement about terminology during the agency transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedRemoved the 403 error page wrapper and the Home link, indicating the error UI was removed or bypassed. The change affects navigation/placeholder UI but does not alter the study details content.SummaryDifference0.5%

Stay in the know with updates to Phase 2 DaxibotulinumtoxinA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.